Mitoxantrone Active Not Recruiting Phase 1 Trials for Acute Myelogenous Leukaemia (AML) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01830777Brentuximab Vedotin + Re-induction Chemotherapy for AML